Entering text into the input field will update the search result below

Goldman's Terence Flynn says a study published in a medical journal suggests branded VEGF drugs...

Goldman's Terence Flynn says a study published in a medical journal suggests branded VEGF drugs such as Regeneron's (REGN +2.7%) Eylea "are superior to off-label Avastin." In the cited study, patients on Lucentis realized a 13 letter improvement in vision versus an 11 letter improvement for those on Avastin.

Recommended For You

About REGN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
REGN--
Regeneron Pharmaceuticals, Inc.